Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "r" return 13 results.
Ceva Returns Strong Double-Digit Growth in 2019; Plans to Double sales by 2020. >
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
Ceva posts strong double-digit growth again in first half of 2015 >
Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates.
Ceva Animal Health posts strong double-digit growth again in 2014 >
Sales grew in all zones and across all species
Ceva Animal Health Merges All R&D Activity >
Dr. Steve Chu Becomes Member of Executive Committee
Ceva Rapid Growth Expected to Continue in 2013 >
North America Zone Reinforces Commitment to Veterinary Profession
Ceva Achieves Best Performance >
The Poultry Site reports Ceva achieved its best performance in history last year with sales up by 18.5 per cent, a 60 per cent margin - up by 24.6 per cent - and an operating profit of €66 million.
Ceva's New Poultry Vaccine Production Facility >
Ceva Animal Health (Ceva), a wholly owned US subsidiary of Ceva Santé Animale and a leading player in the global animal health industry, launched a new poultry vaccine production facility in May 2011.
Joint venture agreement between Ceva and Huadu signed in Beijing >
"Ceva Huadu" to become innovation and R&D platform for biologicals
Dr. Steve Chu joins Ceva >
Addition to talented team positions Ceva for continued growth
Company Overview >
Present in 46 countries, with over 6000 employees worldwide.